2017

The Irene Diamond Fund/AFAR Postdoctoral Transition Awards in Aging


Xu ming 20180718 copy

Ming Xu, PhD

Postdoctoral Fellow, Mayo Clinic

Using senolytic drugs to alleviate age-related frailty and inflammation

Senescent cells induce inflammation in healthy organ tissue that could link them to age-related inflammation as well as frailty. The goal of this study is to better understand the role of cellular senescence in physical dysfunction, and to develop strategies to reduce frailty and improve physical function and resilience in an aging population. In the proposed study, Dr. Ming Xu will specifically examine if senescent, or “old”, cells cause frailty in aging adults, and whether senolytic drugs, which kill senescent cells, can reduce frailty while clearing out these “old” cells.

More 2017 Recipients of this Grant

Sebastian Brandhorst, Dr. rer. nat

A fast-mimicking diet delays aging phenotypes by senolytic targeting of p16-positive senescent cells in vivo

Yejing Ge, PhD

Investigating stem cell lineage infidelity in aged skin

Geraldine Gontier, PhD

Role of Tet2 in regulating regenerative and cognitive rejuvenation in the aging brain

Rizwan Qaisar, PhD

Activation of the SERCA ATPase as an intervention for Sarcopenia

Payel Sen, PhD

Epigenetic mechanisms contributing to loss of transcriptional fidelity during senescence and aging